Recent studies have shown that COL6A1 expression is significantly elevated in the tumor stem cells of GBM, is involved in interaction with the extracellular matrix [51], and is a key gene associated with anti-vascular endothelial growth factor therapy [52]. This evidence concerns the gene COL6A1 and glioblastoma.